Nitrosative stress predicts the presence and severity of nonalcoholic fatty liver at different stages of the development of insulin resistance and metabolic syndrome: Possible role of vitamin a intake

American Journal of Clinical Nutrition

Volumn 86, Issue 3, 2007, Pages 661-671

  Musso, Giovanni ^a   Gambino, Roberto ^b   De Michieli, Franco ^b   Biroli, Giampaolo ^b   Premoli, Alberto ^b   Pagano, Gianfranco ^b   Bo, Simona ^b   Durazzo, Marilena ^b   Cassader, Maurizio ^b  

^a GRADENIGO HOSPITAL   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

Adipokines; Microsomal triacylglycerol transfer protein; MTP polymorphism; Nitrotyrosine; Retinoid

Indexed keywords

3 NITROTYROSINE; ADIPOCYTOKINE; ALPHA TOCOPHEROL; INSULIN; INTERLEUKIN 6; LEPTIN; RESISTIN; RETINOL; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE COURSE; FEMALE; GENETIC POLYMORPHISM; HOMEOSTASIS; HUMAN; HUMAN TISSUE; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIVER DISEASE; LIVER HISTOLOGY; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; OXIDATIVE STRESS; PATHOGENESIS; VITAMIN INTAKE;

EID: 34548804940     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/86.3.661     Document Type: Article

References (48)

1. Clark JM, Brancati FL, Diehl AM. Nonalcoholic fatty liver disease. Gastroenterology 2002;122:1649-57.
2. Pagano G, Pacini G, Musso G, et al. Nonalcoholic steatohepatitis, insulin resistance and metabolic syndrome: further evidence for an etiologic association. Hepatology 2002;35:367-72.
3. Trombetta M, Spiazzi G, Zoppini G, Muggeo M. Type 2 diabetes and chronic liver disease in the Verona Diabetes Study. Aliment Pharmacol Ther 2005;22(suppl): 24-7.
4. Lonardo A, Bombardini S, Scaglioni F, et al. Hepatic steatosis and insulin resistance: does etiology make a difference? J Hepatol 2006;44:190-6.
5. Pacher P, Szabo C. Role of peroxynitrite in the pathogenesis of cardiovascular complications of diabetes. Curr Opinion Pharmacol 2006;6:136-41.
6. Yanagitani A, Yamada S, Yasui S, et al. Retinoid acid receptor á dominant negative form causes steatohepatitis and liver tumors in transgenic mice. Hepatology 2004;40:366-75.
7. Westerbacka J, Lammi K, Hakkinen AM, et al. Dietary fat content modifies liver fat in overweight nondiabetic subjects. J Clin Endocrinol Metab 2005;90:2804-9.
8. Namikawa C, Shu-Ping Z, Vyselaar JR, et al. Polymorphisms of microsomal triglyceride transfer protein gene and manganese superoxide dismutase gene in non-alcoholic sttohepatitis. J Hepatol 2004;40:781-6.
9. Hamaguchi M, Kojima T, Takeda N, et al. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Ann Internal Med 2005;143:722-8.
10. Karpe F, Lundahl B, Ehrenborg E, Eriksson P, Hamsten A. A common functional polymorphism in the promoter region of the microsomal triglyceride transfer protein gene influences plasma LDL levels. Arterioscler Thromb Vasc Biol 1998;18:756-61.
11. Musso G, Gambino R, Durazzo M, et al. Adipokines in NASH: postprandial lipid metabolism as a link between adiponectin and liver disease. Hepatology 2005;42:1175-83.
12. Bonora E, Targher G, Alberiche M, et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity. Studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 2000;23:57-63.
13. Yokoyama H, Emoto M, Fujiwara S, et al. Quantitative insulin sensitivity check index and the reciprocal index of homeostasis model assessment in normal range weight and moderately obese type 2 diabetic patients. Diabetes Care 2003;26:2426-32.
14. Yip J, Facchini FS, Reaven GM. Resistance to insulin-mediated glucose disposal as a predictor of cardiovascular disease. J Clin Endocrinol Metab 1998;83:2773-6.
15. Facchini FS, Hua N, Abbasi F, Reaven GM. Insulin resistance as a predictor of age-related diseases. J Clin Endocrinol Metab 2001;86:3574-8.
16. Jackson AS, Stanforth PR, Gagnon J, et al. The effect of sex, age, and race on estimating percentage body fat from body mass index: the Heritage Family Study. Intern J Obes 2002;26:789-96.
17. Brunt EM. Nonalcoholic steatohepatitis: definition and pathology. Semin Liver Dis 2001;21:3-16.
18. Prati D, Taioli E, Zanella A, et al. Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann Intern Med 2002;137:1-9.
19. Chang Y, Ryu S, Sung E, Jang Y. Higher concentrations of alanine aminotransferase within the reference interval predict non-alcoholic fatty liver disease. Clin Chem 2007;53:686-92 (Epub 2007 Feb 1).
20. Pisani P, Faggiano F, Krogh V, Palli D, Vineis P, Berrino F. Relative validity and reproducibility of a food frequency dietary questionnaire for use in the Italian EPIC centres. Int J Epidemiol 1997(suppl):S152-60.
21. Sacerdote C, Fiorini L, Dalmasso M, Vineis P. Alimentazione e rischi di cancro. Indagine su un campione di 10054 volontari residenti nell'area torinese. (Dietary habits and the risk of cancer. Investigation in a sample of 101 054 volunteer residents of the Turin area.) Turin, Italy: AGAT, 2000 (in Italian).
22. Carnovale E, Marletta. Food composition table. Istituto Nazionale della Nutrizione. Milan, Italy: EDRA, 1997.
23. Salvini S, Parpinel M, Gnagnarella P, Maisonneuve P, Turrini A. Banca Dati di Composizione degli Alimenti per Studi Epidemiologici in Italia. (Food composition database for epidemiological studies in Italy.) Milan, Italy: Istituto Europeo di Oncologia, 1988 (in Italian).
24. Sanyal AJ, Campbell-Sargent C, Mirshahi F, et al. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology 2001;120:1183-92.
25. LARN - Livelli di assunzione giornalieri raccomandati di nutrienti per la popolazione italiana. (Recommended daily nutrient intakes for the Italian population.) Rome, Italy: Società di Nutrizione Umana, 1996. Internet: www.inran.it.
26. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of. the metabolic syndrome. An AHA/NHLBI scientific Statement. Circulation 2005;112:2735-52.
27. Birkner E, Kasperczyk S, Kasperczyk A, et al. Metabolic and antioxidative changes in liver steatosis induced by high-fat, low-carbohydrate diet in rabbits. J Physiol Pharmacol 2005;56:45-58.
28. Botham KM, Zheng X, Napoletano M, et al. The effects of dietary n-3 polyunsaturated fatty acids delivered in chylomicron renmants on the transcription of genes regulating synthesis and secretion of very-low-density lipoprotein by the liver: modulation by cellular oxidative state. Exp Biol Med 2003;228:143-51.
29. Pan M, Cederhaum AI, Zhang YL, Ginsberg HW, Williams KJ, Fisher FA. Lipid peroxidation and oxidant stress regulate hepatic apolipoprotein B degradation and VLDL production. J Clin Invest 2004;113:1277-87.
30. Ikura Y, Ohsawa M, Suekane T, et al. Localization of oxidized phosphatidylcholine in non-alcoholic fatty liver disease: impact on disease progression. Hepatology 2006;43:506-14.
31. Sattar N, Scherbakova O, Ford I, et al. Elevated alanine aminotransferase predicts new-onset type 2 diabetes independently of classical risk factors, metabolic syndrome, and C-reactive protein in the West of Scotland Coronary Prevention Study. Diabetes 2004;53:2855-60.
32. Lieber CS. CYP2E1: from ASH to NASH. Hepatol Res 2004;28:1-11.
33. Shiota G. Loss of function of retinoic acid in liver leads to steatohepatitis and liver tumor: a NASH animal model. Hepatology Res 2005;33:155-60.
34. Ikeda R, Uehara M, Takasaki M, et al. Dose-responsive alteration in hepatic lipid peroxidation and retinol metabolism with increasing dietary beta-carotene in iron deficient rats. Int J Vitam Nutr Res 2002;72:321-8.
35. Noyan S, Cavusoglu I, Minboy FZ. The effect of vitamin A on CCl4-induced hepatic injuries in rats; a histochemical, immunohistochemical and ultrastructural study. Acta Histochem 2006;107:421-34.
36. Seifert WF, Bosma A, Brounver A, et al. Vitamin A deficiency potentiates carbon tetrachloride-induced liver fibrosis in rats. Hepatology 1994;19:193-201.
37. Krinsky NJ. Antioxidant functions of carotenoids. Free Radic Biol Med 1989;7:617-35.
38. Hu T, Foxworthy P, Siesky A, et al. Hepatic peroxisomal fatty acid β-oxidation is regulated by liver X receptor α. Endocrinology 2005;146:5380-7.
39. Wu Y, Zhang X, Bardag-Gorce F, et al. Retinoid X receptor α regulates glutathione homeostasis and xenobiotic detoxification processes in mouse liver. Mol Pharmacol 2004;65:550-7.
40. Davis BH, Kramer RJ, Davidson NO. Retinoic acid modulates rat Ito cells proliferation, collagen, and transforming growth factor β production. J Clin Invest 1990;86:2062-70.
41. Allard JP, Ruyall D, Kurian R, Muggli R, Jeejeeboy KN. Effects of beta-carotene supplementation on lipid peroxidation in humans. Am J Clin Nutr 1994;59:884-90.
42. Cha BS, Ciaraldi TP, Carter L, et al. Peroxisome proliferator-activated receptor (PPAR) γ and retinoid X receptor(RXR) agonists have complementary effects on glucose and lipid metabolism in human skeletal muscle. Diabetologia 2001;44:444-52.
43. Vuppalanchi R, Marri S, Kolwankar D, Considine RV, Chalasani N. Is adiponectin involved in the pathogenesis of non-alcoholic steatohepatitis? A preliminary human study. J Clin Gastroenterol 2005;39:237-42.
44. Liu YX, Wang JZ, Liu JP, Pang CK, Jia HY. [Imaging diagnosis for fatty liver: a systematic review.] Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2004;26:580-4 (in Chinese).
45. Forman MR, Lanza E, Yong LC, et al. The correlation between two dietary assessments of carotenoid intake and plasma carotenoid concentrations: application of a carotenoid food-composition database. Am J Clin Nutr 1993;58:519-24.
46. Johnson EJ, Suter PM, Sahyoun N, Ribaya-Mercado JD, Russell RM. Relation between Beta-carotene intake and plasma and adipose tissue concentrations of carotenoids and retinoids. Am J Clin Nutr 1995;62:598-603.
47. Mayne ST. Antioxidant nutrients and chronic disease: use of biomarkers of exposure and oxidative stress status in epidemiologic research. J Nutr 2003;133(suppl):S933-40.
48. Shiota G, Tsuchiya H, Hoshikawa Y. The liver as target organ of retinoids. Hepatol Res 2006;36:248-54.